The North America Endovascular Aneurysm Repair Market would witness market growth of 4.2% CAGR during the forecast period (2022-2028).
Endovascular aneurysm repair is a minimally invasive procedure that uses a specialized stent transplant known as an endograft. An aneurysm arises when the walls of the arteries become weaker, and the artery enlarges, much like a balloon, as the blood pressure beats against the weakening artery walls. An endovascular stent graft is placed in an aortic aneurysm to do this endovascular repair.
An aneurysm is a condition in which the artery wall enlarges due to weakness or deterioration. It is commonly linked to the use of tobacco and smoking. Aneurysms are also more common in those who have medical disorders including atherosclerosis, excessive cholesterol, or connective tissue illness. Endovascular aneurysm repair (EVAR) is a minimally invasive method or surgery for the repair of these aneurysms. The covered stent, a metal mesh tube with a coating of fabric, is inserted into the weak portion of the artery during the EVAR operation. This allows blood to circulate freely without pooling in the bulge, preventing it from exploding. Aneurysms can now be treated with a variety of technologies available on the market.
The U.S. government enacted the Screening Abdominal Aortic Aneurysms Very Efficiently (SAVE) Act in 2014, which provides one free AAA screening to men who have smoked at least once in their lives and women with a family history of the ailment. Furthermore, large government reimbursements in industrialized countries are another aspect boosting overall industry growth. In the United States, for example, Medicare provides one abdominal aortic ultrasound for patients at risk. The National Health Service (NHS) and the United States Food and Drug Administration (FDA) are attempting to reduce the occurrence of aortic aneurysm.
The US market dominated the North America Endovascular Aneurysm Repair Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $963.5 million by 2028. The Canada market is anticipated to grow at CAGR of 6.5% during (2022 - 2028). Additionally, The Mexico market would showcase a CAGR of 5.6% during (2022 - 2028).
Based on Indication, the market is segmented into Abdominal and Thoratic. Based on Product, the market is segmented into Percutaneous Evar, Fenestrated Evar, Aortic Stents & Taa Graft, and Others. Based on Site, the market is segmented into Infrarenal and Pararenal. Based on Anatomy, the market is segmented into Traditional and Complex. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Endovascular Aneurysm Repair Market is Estimated to reach $3.6 Billion by 2028, at a CAGR of 4.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Endologix LLC, Lombard Medical Limited, Cardinal Health, Inc., Becton, Dickinson and Company, Medtronic PLC, Cook Medical, Inc., Koninklijke Philips N.V., Terumo Corporation, Abbott Laboratories, and Artivion, Inc.
By Indication
By Product
By Site
By Anatomy
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
